Morgan, Eric E <br/><br/>
Chronic treatment with trimetazidine reduces the upregulation of atrial natriuretic peptide in heart failure.  [electronic resource] 

 -  Fundamental & clinical pharmacology  Oct 2006 
 - 503-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0767-3981 
<br/><br/><label>Standard No.: </label>10.1111/j.1472-8206.2006.00424.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyl-CoA Dehydrogenase--genetics<br/>Animals<br/>Atrial Natriuretic Factor--biosynthesis<br/>Carnitine O-Palmitoyltransferase--genetics<br/>Male<br/>Myocardial Infarction--drug therapy<br/>Palmitoyl-CoA Hydrolase--genetics<br/>Protein Kinases--genetics<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Wistar<br/>Trimetazidine--pharmacology<br/>Up-Regulation--drug effects<br/>Vasodilator Agents--pharmacology<br/>Ventricular Function, Left--drug effects